4.7 Article

Conserved Herpesviral Kinase Promotes Viral Persistence by Inhibiting the IRF-3-Mediated Type I Interferon Response

Journal

CELL HOST & MICROBE
Volume 5, Issue 2, Pages 166-178

Publisher

CELL PRESS
DOI: 10.1016/j.chom.2008.12.013

Keywords

-

Funding

  1. NIH [R01-DE15752, R21-CA120761, P01-DE019085, DE015612, P50-CA86306, R01-A159603, T32A1060567]
  2. UCLA AIDS Institute
  3. UCLA Center for AIDS Research [A128697]
  4. Universitywide AIDS Research Program Dissertation Award [D06-LA-4]
  5. Irvington Institute for Immunological Research.

Ask authors/readers for more resources

A conserved herpesviral kinase, designated ORF36 in murine gamma-herpesvirus 68 (MHV-68), plays multiple vital roles in the viral life cycle. Here, we show by screening mutant viruses that ORF36 counteracts the antiviral type I interferon (IFN) response. ORF36 specifically binds to the activated form of interferon regulatory factor 3 (IRF-3) in the nucleus, inhibiting IRF-3 interaction with the cotranscriptional activator CBP and thereby suppressing the recruitment of RNA polymerase II to the interferon beta promoter. The anti-IFN function of ORF36 is conserved among herpesvirus subfamilies, although the conserved kinase activity is not absolutely required for this function. MHV-68 lacking ORF36 induces a greater interferon response and is attenuated in vitro and in vivo, where acute viral infection in the lung and latency in the spleen are compromised. Our data suggest that herpesviruses have evolved within their conserved kinase an anti-IFN activity critical for evasion of host immunity and for persistence.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available